Eric Crombez is listed as a director on 1 SEC Form D filing by 1 issuer in Aug 2026: Epicrispr Biotechnologies, Inc. (South San Francisco, CA — biotechnology — 2026; $176.8M reported sold to 47 investors).
What this means One deal on file with the SEC, filed Aug 2026. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Amber Salzman (1 shared filing), Andrew Lam (1 shared filing), Anran Li (1 shared filing), Haorui Zhang (1 shared filing), Jennifer King (1 shared filing) and 1 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Eric. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — 1 court case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Eric Crombez and found 1 difference, 1 worth asking the sponsor about: Form D filed 3,036 days after the first sale.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.